This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What's in Store for Las Vegas Sands (LVS) in Q3 Earnings?
by Zacks Equity Research
Las Vegas Sands' (LVS) third-quarter 2019 top line is anticipated to reflect decline in revenues at Sand Cotai Central.
MGM Resorts (MGM) Sells Properties in a Move to Free Capital
by Christopher Vargas
The sale will free up cash, offering MGM flexibility to operate in new and different ways, said MGM Resorts Chairman and CEO Jim Murren.
MGM Resorts to Sell 2 Casinos, Focus on Asset Light Strategy
by Zacks Equity Research
MGM Resorts (MGM) announces separate deals to sell MGM Resorts' Bellagio and Circus Circus Las Vegas.
Penn National Gaming Banks on Sports Betting for Growth
by Zacks Equity Research
Penn National Gaming's (PENN) strong brand presence and efforts to expand its sports betting presence bode well.
Gambling Stock Roundup: CNTY-Mountaineer Casino Update Deal, CZR-WYND Extend Tie Up
by Zacks Equity Research
Concerns over the trade war between Beijing and Washington result in disappointing performance by gambling stocks over the last five trading days.
Factors Likely to Shape Vail Resorts' (MTN) Earnings in Q4
by Zacks Equity Research
Vail Resorts' (MTN) revenues in fourth-quarter fiscal 2019 are likely to be driven by robust performance of the Mountain segment.
Higher Ticket Revenues to Drive Carnival's (CCL) Q3 Earnings
by Zacks Equity Research
Carnival's (CCL) top line in third-quarter fiscal 2019 is likely to be driven by an increase in passenger ticket revenues as well as Onboard and Other revenues.
The Zacks Analyst Blog Highlights: MGM, Caesars and Churchill Downs
by Zacks Equity Research
The Zacks Analyst Blog Highlights: MGM, Caesars and Churchill Downs
Gambling Stock Roundup: Macau's Gaming Revenues Decline, Roar Digital Launches BetMGM
by Zacks Equity Research
Macau witnesses Gross Gaming Revenue decline in August. However, MGM Resorts (MGM) and Caesars Entertainment (CZR) continues to expand sports betting footprint.
Caesars Entertainment (CZR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Caesars (CZR) delivered earnings and revenue surprises of -100.00% and 1.32%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Caesars Entertainment (CZR) Q2 Earnings?
by Zacks Equity Research
Caesars Entertainment's (CZR) top line in second-quarter fiscal 2019 is likely to be driven by robust consumer demand environment in Las Vegas and the company's focus on operation execution.
Gambling Stock Roundup: MGM & LVS' Q2 Picture Disappoints, MLCO & MCRI Earnings Beat
by Zacks Equity Research
MGM Resorts International (MGM) and Las Vegas Sands Corp (LVS) reports lower-than-expected quarterly numbers in Q2.
Analysts Estimate Caesars Entertainment (CZR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Caesars (CZR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MGM Resorts (MGM) Earnings & Revenues Miss Estimates in Q2
by Zacks Equity Research
MGM Resorts' (MGM) second-quarter 2019 revenues gain from a robust performance by MGM China despite missing estimates.
Sports Betting & Esports: What's Next and How to Invest
by Benjamin Rains
Welcome to the latest episode of the Full-Court Finance podcast from Zacks Investment Research where Associate Stock Strategist Ben Rains dives into the latest news from the world of legalized sports gambling and esports.
What Makes Caesars Entertainment (CZR) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Caesars Entertainment (CZR) have what it takes to be a top stock pick for momentum investors? Let's find out.
Implied Volatility Surging for Caesars (CZR) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Caesars (CZR) stock based on the movements in the options market lately.
Abbvie Decides to Acquire Allergan
by Zacks Equity Research
Abbvie Decides to Acquire Allergan
AbbVie to Buy Botox-Maker Allergan, Look Ahead to G-20
by Mark Vickery
AbbVie (ABBV) has agreed to purchase Botox maker Allergan (AGN) for roughly $63 billion in cash and stock.
Company News For Jun 25, 2019
by Zacks Equity Research
Companies In The News Are: CZR,ERI,BMY,CELG,KO,VZ
Caesars (CZR) Stock Jumps After Agreeing to $8.5 Billion Deal
by Zachary Stutler
Caesars Entertainment (CZR) stock jumped over 15% Monday after news broke that the company agreed to merge with Eldorado Entertainment (ERI).
Eldorado to Buy Caesars
by Zacks Equity Research
Eldorado to Buy Caesars
U.S. Senate Takes on Big Tech, Plus "Merger Monday"
by Mark Vickery
Eldorado Resorts (ELR) has agreed to buy Caesars (CZR) for $8.6 billion, and a bipartisan bill in the Senate holds Big Tech accountable for monetized user data.
Gambling Stock Roundup: Macau Gaming Revenues Solid, MGM Announces Job Cuts
by Zacks Equity Research
Macau witnesses an increase in Gross Gaming Revenue (GGR) in May. However, flagging China property price continues to impact the high-end VIP segment.
The Zacks Analyst Blog Highlights: Wynn Resorts, MGM Resorts International, Walt Disney, Caesars Entertainment and Stars Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Wynn Resorts, MGM Resorts International, Walt Disney, Caesars Entertainment and Stars Group